Filing Details

Accession Number:
0001144204-18-014636
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-14 16:01:14
Reporting Period:
2018-03-12
Accepted Time:
2018-03-14 16:01:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1279704 Cellectar Biosciences Inc. CLRB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202770 V James Caruso C/O Cellectar Biosciences, Inc.
3301 Agriculture Drive
Madison WI 53716
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-03-12 34,000 $1.20 213,548 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2017 to satisfy tax withholding obligations upon vesting of restricted stock.
  2. The price reported in Column 4 of Line 1 with respect to the 34,000 shares sold on March 12, 2018 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.17 to $1.26. The Reporting Person has provided to the Issuer, and undertakes to provide to any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnote (2) to this Form 4.